Effects of non-toxic doses of ouabain on sodium, potassium, calcium distribution in guinea pig papillary muscle. Electronprobe microanalysis.
The mechanisms and the cellular structures which are definitely involved in the accumulation and release of calcium in heart muscle treated with cardiac glycosides are not yet known. The distribution of sodium, potassium and calcium in small papillary muscles of the guinea pig right ventricle was examined with the aid of energy dispersive x-ray microanalysis and cryotechniques. The primary aim of the present study was twofold: firstly, to determine whether an increase in intracellular sodium concentration is detectable in muscles showing positive inotropy resulting from treatment with non-toxic doses of ouabain; and secondly, whether at the end of diastole cellular stores are detectable accumulating Ca which could be responsible for the pronounced contraction which normally would follow. Analyses on interstitium, cell membrane, sarcomeres, Z-lines and mitochondria of 7 muscles strips treated with non-toxic doses of ouabain and frozen at the end of diastole showed the following: sodium concentration in the sarcoplasm was significantly higher than over the mitochondria; it was also higher than over the sarcoplasm of non-treated muscles frozen at the end of diastole. High calcium concentrations were also measured over the cell membrane. These calcium concentrations were higher than that detected in sarcomeres, Z-lines and mitochondria. Over the sarcomeres, the calcium concentration was higher than in experiments on non-treated muscles which were also frozen at the end of diastole. Mitochondria did not accumulate any detectable concentration of calcium.(ABSTRACT TRUNCATED AT 250 WORDS)
D000818:Animals; D002118:Calcium / Q000032:analysis*; D002451:Cell Compartmentation; D004577:Electron Probe Microanalysis; D005615:Freezing; D006168:Guinea Pigs; D008929:Mitochondria, Heart / Q000032:analysis; D009119:Muscle Contraction / Q000187:drug effects; D010042:Ouabain / Q000494:pharmacology*; D010210:Papillary Muscles / Q000032:analysis / Q000187:drug effects*; D011188:Potassium / Q000032:analysis*; D012508:Sarcolemma / Q000032:analysis; D012518:Sarcomeres / Q000032:analysis; D012964:Sodium / Q000032:analysis*; D013268:Stimulation, Chemical
D010042:Ouabain; D012964:Sodium; D011188:Potassium; D002118:Calcium